University of Siena

Yunnan Cancer Hospital enhances cancer care with advanced imaging and immunotherapy techniques, improving early detection and treatment outcomes, particularly for breast cancer. The hospital's multidisciplinary approach includes innovative optical molecular imaging and targeted therapies, aiming to boost immunotherapy efficacy and develop personalized treatments.

Case Western Reserve University researchers helped uncover evidence of ritualistic gatherings in Manot Cave, Galilee, Israel, dated to 35,000 years ago. The cave, used by Neanderthals and humans, features a cavern with a turtle-engraved rock possibly used for rituals. Dental students played a crucial role in identifying bone fragments during the excavation.

Violet-blue light (VBL) technology, effective at inactivating pathogens and safe for human exposure, is analyzed for its potential in reducing hospital-acquired infections (HAIs). VBL, compared to UV, offers continuous disinfection in occupied environments, with limited safety concerns and positive environmental impact. Implementing VBL could be a significant step in combating environmental contamination and reducing HAIs.

ModeX Therapeutics, an OPKO Health company, appoints Dr. Giovanni Abbadessa as Chief Medical Officer to lead oncology development of multispecific antibodies. Dr. Abbadessa, with 20+ years of experience, previously served as VP at Sanofi, bringing expertise in early-stage oncology and clinical development.